UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 10-K




... | March 31, 2023

Related Keywords

State Of New Jersey , New Jersey , United States , Delaware , Hong Kong , United Kingdom , Turkey , Taiwan , Massachusetts , China , California , Australia , Russia , Virginia , Colorado , Macau , Japan , Connecticut , Ukraine , Nevada , Washington , Sydney , New South Wales , South Africa , Canada , Russian , Canadian , America , Russian Federation , American , David Hastings , Brian Philippe Tinmouth , Marco Taglietti , Azoles Noxafil , Stevenc Gilman , Christine Coyne , Histoplasmaandblastomycesgenera Candidaandaspergillusgenera , Armando Anido , Annf Hanham , Evertrust Plaza , Scott Sukenick , David Angulo , Ivor Macleod , Guggenheim Securities , Medicaid Services , Us Department Of Justice , Us Supreme Court , European Union , Amplyx Pharmaceuticals Inc , Puissance Life Science Opportunities Fund Vi , Athersys Inc , Officers Of The Company , Data Review Committee , Corporate Governance Committee , European Union Withdrawal , Development Accruals , Mycovia Pharmaceuticals Inc , Healthcare Regulatory Agency , Name Of Each Exchange On Which , Centers For Medicare , Jersey Technology Business Tax Certificate Transfer , Public Company Accounting Oversight Board United States , Ladenburg Thalmann Co , Centers For Disease Control , Merck Co Inc , Exchange Commission , Hercules Capital Inc , Pacific Pty Ltd , United States Court , Centers For Medicare Medicaid Services , European Medicines Agency , National Institutes Of Health , Cantor Fitzgerald Co , Health Care , Waterstone Pharmaceutical Hk Limited Or , Jersey Economic Development Authority , United Cypralis Limited Or , Health Information Technology For Economic , Scynexis Inc , Children Health Insurance Program , Biden Administration , Iv Ibrexafungerp Development Program , Merck Sharp Dohme Corp , Corporation Law , World Health Organization , Silicon Valley Bank , Amplity Health , Clinical Health , Trademark Office , Key Development Milestones , Human Services , Office Of Inspector , Nasdaq , While The Company , Federal Reserve , Commission File Number , Us Department Of Health , Pfizer , Supreme Court , Health Insurance Portability , Department Of Justice , Waterstone , Centers For Disease , Silicon Valley Bank The Loan Agreement , Cidara Therapeutics Inc , Case Western Reserve University , California Department Of Financial Protection , Clinical Development Arrangements , Jiangsu Hansoh Pharmaceutical Group Company , Securities Exchange , Matinas Biopharma Holdings Inc , Exchange Act Rule , Development Expense , Community Clinical Programs , Our Core Drug Development Operations , Government Accountability Office , Drug Administration , Company On , Hansoh Shanghai Health Technology Co Ltd , Deposit Insurance Corporation , California Privacy Protection Agency , Mark One , Zip Code , Each Exchange , Securities Exchange Act , Interactive Data File , Regulations T , Sarbanes Oxley Act , Exchange Act , Common Stock , Nasdaq Global Market , Annual Report , Securities Act , Financial Condition , License Agreement , Regulatory Approval , Product Candidates For Human , Employee Matters , Risks Relating , Glaxosmithkline Intellectual Property , Greater China , Hart Scott Rodino Antitrust Improvements Act , Licensing Agreements Associated , Core Drug Development Operations , Hercules Capital , Silicon Valley Bridge Bank , Security Agreement , Loan Agreement , First Amendment , Qualified Infectious Disease Product , Fast Track , Orphan Drug , Orphan Medicinal Product , Innovation Passport , Generating Antibiotic Incentives Now , Community Clinical , Invasive Fungal Infections , Disease Control , Antibiotic Resistance Threats , Century Cures Act , National Institutes , Mycovia Pharmaceuticals , Cidara Therapeutics , Melinta Therapeutics , Core Drug Development , Merck Sharp , Deferred Milestone , Exclusive License , Collaboration Agreement , Central Asian , Middle Eastern , North African , Federal Food , Cosmetic Act , Post Marketing Requirements , Prescription Drug Marketing Act , Federal Trade Commission Act , California Consumer Privacy Act , Canadian Personal Information Protection , Electronic Documents Act , Anti Spam Legislation , General Data Protection Regulation , Payment Card Industry Data Security Standard , Consumer Data Protection Act , Colorado Privacy , California Privacy Rights Act , Inspector General , Anti Kickback Statute , Patient Protection , Affordable Care Act , Education Reconciliation Act , False Claims Act , Federal Health Insurance Portability , Accountability Act , Physician Payments Sunshine Act , Health Insurance Program , Health Information Technology , Clinical Health Act , Affordable Care , President Biden , Inflation Reduction Act , Infrastructure Investment , Jobs Act , American Taxpayer Relief Act , American Economy , Comprehensive Plan , Addressing High Drug Prices , Medicaid Innovation , Drug Price Competition , Patent Term Restoration Act , Hatch Waxman Act , Factors Risks Relating , Intellectual Property , Jersey City , Puissance Life Science Opportunities Fund , California Department , Financial Protection , Risk Evaluation , Mitigation Strategy , Generating Antibiotic Incentives Now Act , Tax Cuts , Good Manufacturing Practices , False Claims , Federal Circuit , Data Protection Regulation , European Economic Area , Owning Our Common , Delaware General Corporation Law , Silicon Valley , Equity Securities , Note Regarding Forward Looking , Chief Executive Officer , Chief Medical Officer , Chief Financial Officer , Chief Commercial Officer , Cantor Fitzgerald , Ladenburg Thalmann , Aspire Capital , Years Ended December , Ended December , Product Revenues For , Development For , Debt Issuance Costs , Cdiscount For , Income For , Expense For , Liabilities Fair Value , Liabilities Fair Value Adjustment For , Tax Benefit For , New Jersey Net Operating Losses , Cash Needs , Accounting Judgments , Accounting Standards Codification , Patient Assistance Programs , Trade Discounts , Collaborative Arrangements , Fair Value , Stock Based Compensation , Accounting Bulletin , Public Company Accounting Oversight Board , Significant Accounting , Accounting Standards Codification Topic , Critical Audit Matter Was Addressed , Going Concern , Term Loan , Federal Deposit Insurance Corporation , Wholesaler Fees , Stocking Fees , Convertible Senior Notes , Diluted Net Loss , Earnings Per , Earnings Per Share , Chief Executive , Pty Ltd , Prior Year , Financial Instruments Credit Losses , Financial Instruments , Own Equity , Convertible Instruments , First Performance Milestone , Maturity Date , Prime Rate , Wall Street Journal , Senior Convertible Note Purchase Agreement , Purchase Agreement , Deferred Fees , Please The , Potential Future , Dohme Corp , Outstanding Common , Restated Certificate , Stock Purchase Agreement , Common Stock Purchase Agreement , Stock Purchase , Common Stock Purchase , Controlled Equity , Equity Underwriting Agreement , Distinguishing Liabilities , Danforth Advisors , United Kingdom Based Cypralis Limited , Waterstone Pharmaceutical , New Jersey Economic Development Authority , Internal Revenue Code , Income Taxes , Incentive Plan , Effective Date , Option Plan , Stock Purchase Plan , Internal Revenue , Liabilities Measured , Identical Assets , Unobservable Inputs , Disclosure Controls , Internal Control , Internal Control Integrated Framework , Sponsoring Organizations , Internal Control Over Financial , Proxy Statement , Its Committees , Section Reports , Business Conduct , Certain Beneficial Owners , Compensation Plan Information , Accountant Fees , Financial Statements , Financial Statement , Principal Executive Officer , Principal Financial , Accounting Officer , Brian Philippe , Scynexis , Nc Stock Exchange , News , Information , Press Release , United , Securities , End , Exchange , Orm Scyx Us8112922005 ,